Blog - Announcements

Vasomedical, Inc. to Report Third Quarter 2016 Results on November 14, 2016

Management to Hold Investor Conference Call on November 14, 2016 at 1:00 p.m. ET

PLAINVIEW, NY / ACCESSWIRE / November 7, 2016 / Vasomedical, Inc. (PINKSHEETS: VASO) announced today that it will release its financial results for the three months ended September 30, 2016 on Monday, November 14, 2016, before market open.

The Company will host a conference call on Monday, November 14, 2016 at 1:00 p.m. ET featuring remarks by Jun Ma, Ph.D., President and CEO, Peter Castle, Chief Operating Officer, and Michael Beecher, Chief Financial Officer of Vasomedical. To join the conference call, please dial 1-877-407-8033 from the U.S. or 1-201-689-8033, internationally. Please call at least five minutes before the scheduled start time. The conference call will also be available via webcast and can be accessed through the Investor Relations section of Vasomedical’s website, www.vasomedical.com. Please allow extra time prior to the call to visit the site and download any necessary software to listen to the live broadcast.

A replay of the conference call will be available at www.vasomedical.com approximately two hours after completion of the live conference call. To access the replay of the call, which will be available until December 14, 2017, please dial 1-877-481-4010 or international 1-919-882-2331, use the code 10142.

About Vasomedical

Vasomedical is a diversified medical technology company specializing in the manufacture and sale of medical devices and in the domestic sale of diagnostic imaging products and healthcare software solutions as well as in the provision of managed network services. The Company conducts its business through four wholly owned subsidiaries as follows. Vaso Diagnostics, Inc. d.b.a. VasoHealthcare provides professional sales services and is the operating subsidiary for the exclusive sales representation of GE Healthcare diagnostic imaging products in certain market segments. Vaso Technology, Inc. provides network and IT services through two business units: VasoHealthcare IT Corp., a national value added reseller of GE Healthcare IT’s Radiology PACS (Picture Archiving and Communication System) software solutions and related services, including implementation, management and support, and NetWolves Network Services LLC, a managed network services provider with an extensive proprietary service platform to a broad base of customers. Vasomedical Solutions, Inc. manages and coordinates the design, manufacture and sales of EECP® Therapy systems and other medical equipment operations. Vasomedical Global Corp. operates the Company’s China-based subsidiaries. Additional information is available on the Company’s website at www.vasomedical.com.

Investor Contacts:

Michael Beecher
Investor Relations
516-508-5805
mbeecher@vasomedical.com

SOURCE: Vasomedical, Inc.

Link to Yahoo Finance: https://finance.yahoo.com/news/vasomedical-inc-report-third-quarter-130000559.html